Bi‐Functional Topospecific Nanoparticles to Promote Immune‐Tumor Cell Engagement as A New Immunotherapeutic Strategy
Advanced Materials · 2026
DOI: 10.1002/adma.202418838 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2026. Verfasst von Alba Ortuño-Bernal und 9 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Universitat de València-Universitat Politèc…. Hauptthemen laut MEDLINE: Immunotherapy, Metal Nanoparticles, Nanoparticles. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Spanish Government, project, MCIN with funding from European Union NextGenerationEU, CIBER -Consorcio Centro de Investigación Biomédica en Red.
Abstract (Originalsprache)
Cancer immunotherapy has emerged as a promising alternative approach, enabling the body's immune system to fight cancer. Cytotoxic T cells play a pivotal role in recognizing and eliminating tumor cells, and their effectiveness relies on establishing a physical interaction and efficient communication with cancer cells. However, this communication is often disrupted by immune escape mechanisms, allowing cancer progression. A versatile nanoplatform is developed to restore cellular connection using Janus mesoporous silica‐Au nanoparticle (J‐pHLIP‐PD1), including specific binding sites on opposite faces for simultaneous binding to cancer cells and immune cells. The two differential surfaces on the nanoparticle allow orthogonal functionalization with the anti‐PD‐1 antibody that interacts with the PD‐1 receptor in cytotoxic T cells on the gold face and the pH Low Insertion Peptide (pHLIP), which undergoes specific insertion into the tumor cell membrane on the silica face. J‐pHLIP‐PD1 nanoparticles effectively bind the surface of tumor cells and capture T cells, facilitating the formation of immune synapse‐like structures that lead to reduced cancer cell viability in vitro, associated with immunogenic cell death signatures. The therapeutic potential of J‐pHLIP‐PD1 is also demonstrated in an in vivo metastatic melanoma model, where treatment with J‐pHLIP‐PD1 produces a significant decrease in metastatic burden and increases T cell presence. The Janus nanosystem represents an attractive platform that expands the toolbox of immune‐engaging strategies, offering a flexible alternative to conventional immunotherapies that link immune and tumor cells, restoring cell–cell communication for cancer elimination.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Universitat de València-Universitat Politècnica de València, Camino de Vera s/n, Valencia, 46022, Spain.
- Unidad Mixta UPV-CIPF de Investigación en Mecanismos de Enfermedades y Nanomedicina, Valencia, Centro de Investigación Príncipe Felipe, Universitat Politècnica de València, C/ d'Eduardo Primo Yúfera, 3, Valencia, 46012,…
- CIBER de Bioingeniería, Biomateriales y Nanomedicina, Instituto de Salud Carlos III, Bellaterra, 08913, Spain.
- Unidad Mixta de Investigación en Nanomedicina y Sensores, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Universitat Politècnica de València, Avenida Fernando Abril Martorell, Torre 106 A 7planta, Valencia, 460…
ORCID-Profile: Ramón Martínez-Máñez
Förderung
- Spanish Government, project
- MCIN with funding from European Union NextGenerationEU
- CIBER -Consorcio Centro de Investigación Biomédica en Red
- MINECO
- F.J.H thanks MIU for his FPU grant
- Generalitat Valenciana
- Biobanco La Fe
- Fundación Científica Asociación Española Contra el Cáncer
Zitieren
APA
Ortuño-Bernal, A., Clara-Trujillo, S., Lucena-Sánchez, E., Hicke, F. J., Escudero, A., Pradana-López, S., Jiménez-Alduan, N., Díez, P., García-Fernández, A., & Martínez-Máñez, R. (2026). Bi‐Functional Topospecific Nanoparticles to Promote Immune‐Tumor Cell Engagement as A New Immunotherapeutic Strategy. Advanced Materials. https://doi.org/10.1002/adma.202418838
Vancouver
Ortuño-Bernal A, Clara-Trujillo S, Lucena-Sánchez E, Hicke FJ, Escudero A, Pradana-López S, et al. Bi‐Functional Topospecific Nanoparticles to Promote Immune‐Tumor Cell Engagement as A New Immunotherapeutic Strategy. Advanced Materials. 2026. doi:10.1002/adma.202418838
BibTeX
@article{OrtuoBernal2026,
author = {Ortuño-Bernal, Alba and Clara-Trujillo, Sandra and Lucena-Sánchez, Elena and Hicke, Francisco J and Escudero, Andrea and Pradana-López, Sandra and Jiménez-Alduan, Nelia and Díez, Paula and García-Fernández, Alba and Martínez-Máñez, Ramón},
title = {Bi‐Functional Topospecific Nanoparticles to Promote Immune‐Tumor Cell Engagement as A New Immunotherapeutic Strategy},
journal = {Advanced Materials},
year = {2026},
doi = {10.1002/adma.202418838}
}
EUVIMED